HD-OPM Archive
Topics › Supplements & vitamins

Vitamin D3 trials: 5% lower all-cause mortality (borderline), 15% lower cancer mortality

Gokhan Can · Oct 22, 2025 · ♥ 21 reactions · 3 comments · original Facebook post
Supplements & vitaminsCancer
AI summary & key facts

Notes pooled randomized data for vitamin D3: all-cause mortality trend HR 0.95 (0.91-1.00, p=0.07) and cancer mortality HR 0.85 (0.74-0.97). Also links a ScienceDaily report that vitamin D slowed telomere shortening, with the ideal dose unclear.

Vitamin D3

sciencedaily.com/releases/2025/10/251022023132.htm

[RCT] Trend towards 5% reduction in all cause mortality HR=0.95 (0.91 to 1.00, p=0.07). 15% reduced risk of cancer mortality HR=0.85 (0.74 to 0.97).

PaperThe BMJ articlebmj.com
ScienceDailyThis everyday vitamin could be the closest thing we have to an “anti-aging pill”A study found that daily vitamin D supplements helped slow telomere shortening—the cellular process linked to aging and disease. Researchers believe its anti-inflammatory effects may protect DNA. While results are promising, the ideal dose remains unclear, and experts stress that lifestyle choices still matter most for longevity.sciencedaily.com

Research cited

#mortality#vitamins#cancer
← newer: Stiff arteries linked to greater brain nerve fiber injury inolder: Cholesterol as a master regulator of blood stem cells, drivi →